Announced on December 9th, 2021, Moderna Inc., a biotechnology company and a key player in mRNA vaccines, is partnering with Carnegie Mellon University (CMU) to launch an Artificial Intelligence Academy. The academy aims to teach Moderna employees to identify and integrate AI and machine learning solutions into the company ecosystem and into the vaccine distribution pipeline.
CMU Professors across the university, including those from CMU’s Department of Statistics & Data Science and the Tepper School of Business, are collaborating to design and implement Moderna’s AI Academy. The academy will be made up of an immersive curriculum tailored to working professionals and focusing on a broad range of topics including data quality and data visualization, statistical thinking and models, machine learning algorithms and AI ethics.
Moderna employees attending the academy will be able to use their knowledge of AI systems to think strategically and leverage AI solutions to tackle a multitude of issues to improve patient outcomes and maximize the impact of mRNA technologies.
“We believe AI is a key enabler of our ability to build the best version of Moderna now and into the future. This AI academy will enable us to make AI part of the company’s ways of working, part of our DNA. We look forward to driving this with Carnegie Mellon’s team,” Bancel said.
The Computing Community Consortium (CCC) identified potential research topics and possible areas of application for computing solutions in relation to the pandemic in three whitepapers, “Pandemic Informatics: Variants of Concern”, “Pandemic Informatics: Vaccine Distribution, Logistics, and Prioritization” and “Pandemic Informatics: Preparation, Robustness, and Resilience”.
Moderna launched the program with its first cohort of students on December 13th and is targeting early 2022 for the full rollout.